Article Listing - Former Biotech CEO Harkonen convicted of wire fraud

APPOINTMENTS AT DU PONT MERCK

25 May 1992

- Du Pont Merck Pharmac-eutical Co: Pieter Timmermans named vice president of drug discovery. He is replacing Robert Taber,...

FUJISAWA LAUNCHES NOVACT M

25 May 1992

- Fujisawa Pharmaceutical has announced the launch of Novact M (coagulation factor IX). Originally developed by the Chemo-Sero-Therapeutic Research...

NASAL ASPIRIN

25 May 1992

- Researchers at the University of Kentucky have developed an asprin solution to be administered via a nasal spray. The...

CELLTECH AND BAYER IN SEPSIS DEAL

25 May 1992

- Celltech has formulated a deal with Bayer of Germany that should generate

PFIZER'S DIFLUCAN LAUNCHED IN NIGERIA

25 May 1992

- Pfizer Products has launched its new anti-fungal agent Diflucan (fluconazole) in Nigeria. Its clinical efficacy and saftey has been...

US DRUG FIRMS' PUERTO RICO TAX CREDITS

25 May 1992

The average amount of credits per employee for drug firms operating in Puerto Rico is $70,788, against $10,593 per employee...

US SELF-MEDICATION STUDIED

25 May 1992

When Americans have colds, headaches and other common ailments, they now use over-the-counter medicines 38% of the time, compared with...

SNIP DRUGS, ECONOMY AND SOCIAL ENVIRONMENT CONF

25 May 1992

The French pharmaceutical manufacturers' association, SNIP, has organized a conference under the title Drugs, Economy and Social Environ-ment, New Approaches,...

US BIOTECH COS NEED GOVT SUPPORT

25 May 1992

Unless concrete steps are taken by the government, industries and universities to ensure that there is a two-way exchange of...

BAYER ESPANA'S 1991 PROFITS DOWN 21.4%

25 May 1992

Bayer Espana, Spanish subsidiary of the German pharmaceutical group, Bayer, made consolidated pretax profits of 8.9 billion pesetas ($86 million)...

Showing 94031-94040 of 95576 articles